Drug intelligence / Profile preview

Shema oral liquid

Development stage
Preclinical
Lead developer
China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica
Administration
Oral
01

Overview

Shema oral liquid is a traditional Chinese medicine (TCM) approved for the treatment of respiratory diseases. It is a combination of ten different herbal ingredients. Preclinical studies in a lipopolysaccharide (LPS)-induced rat model of chronic obstructive pulmonary disease (COPD) have shown that Shema oral liquid ameliorates the severity of COPD by inhibiting inflammatory responses, improving pulmonary ventilatory function, and alleviating LPS-induced lung injury. Its therapeutic mechanism involves the downregulation of DNA methyltransferase 1 (DNMT1) expression in lung tissue, and it also suppresses the levels of inflammatory cytokines such as interleukin-1 beta, interleukin-6, and tumor necrosis factor alpha.

Other names
Shema
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)DNMT1 (DNA (cytosine-5)-methyltransferase 1)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Shema oral liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shema oral liquid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call